Greenleaf Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,051
| Closed | -$206K | – | 760 |
|
|
2023
Q3 | $206K | Buy |
1,051
+31
| +3% | +$6.08K | ﹤0.01% | 703 |
|
|
2023
Q2 | $214K | Buy |
+1,020
| New | +$214K | ﹤0.01% | 707 |
|
|
2022
Q1 | – | Sell |
-759
| Closed | -$286K | – | 764 |
|
|
2021
Q4 | $286K | Sell |
759
-64
| -8% | -$24.1K | ﹤0.01% | 615 |
|
|
2021
Q3 | $340K | Buy |
823
+74
| +10% | +$30.6K | ﹤0.01% | 528 |
|
|
2021
Q2 | $277K | Buy |
749
+30
| +4% | +$11.1K | ﹤0.01% | 605 |
|
|
2021
Q1 | $208K | Buy |
+719
| New | +$208K | ﹤0.01% | 679 |
|